BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37769336)

  • 1. Net survival of women diagnosed with breast tumours: a population-based study in Switzerland.
    Karavasiloglou N; Michalopoulou E; Limam M; Korol D; Wanner M; Rohrmann S
    Swiss Med Wkly; 2023 Aug; 153():40087. PubMed ID: 37769336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cause-specific or relative survival setting to estimate population-based net survival from cancer? An empirical evaluation using women diagnosed with breast cancer in Geneva between 1981 and 1991 and followed for 20 years after diagnosis.
    Schaffar R; Rachet B; Belot A; Woods L
    Cancer Epidemiol; 2015 Jun; 39(3):465-72. PubMed ID: 25907643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status.
    Bertaut A; Mounier M; Desmoulins I; Guiu S; Beltjens F; Darut-Jouve A; Ponnelle T; Arnould L; Arveux P
    Eur J Cancer Care (Engl); 2015 Nov; 24(6):920-8. PubMed ID: 25757548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease.
    Duffy SW; Tabar L; Vitak B; Day NE; Smith RA; Chen HH; Yen MF
    Eur J Cancer; 2003 Aug; 39(12):1755-60. PubMed ID: 12888371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group.
    Møller P; Reis MM; Evans G; Vasen H; Haites N; Anderson E; Steel CM; Apold J; Lalloo F; Maehle L; Preece P; Gregory H; Heimdal K
    Dis Markers; 1999 Oct; 15(1-3):179-86. PubMed ID: 10595275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing trends in in situ breast cancer incidence in a region with no population-based mammographic screening program: results from Zurich, Switzerland 2003-2014.
    Karavasiloglou N; Matthes KL; Berlin C; Limam M; Wanner M; Korol D; Rohrmann S
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):653-660. PubMed ID: 30547321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in net survival from corpus uteri cancer in six European Latin countries: results from the SUDCAN population-based study.
    Antunes L; Roche L; José Bento M;
    Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S100-S106. PubMed ID: 28005612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.
    Sackey H; Hui M; Czene K; Verkooijen H; Edgren G; Frisell J; Hartman M
    Breast Cancer Res; 2016 Oct; 18(1):105. PubMed ID: 27756431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Get Data Out' Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England.
    van Bodegraven B; Vernon S; Eversfield C; Board R; Craig P; Gran S; Harwood CA; Keohane S; Levell NJ; Matin RN; Proby C; Rajan N; Rous B; Ascott A; Millington GWM; Venables ZC;
    Br J Dermatol; 2023 May; 188(6):777-784. PubMed ID: 36814132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in net survival from head and neck cancer in six European Latin countries: results from the SUDCAN population-based study.
    Guizard AV; Uhry Z; de Raucourt D; Mazzoleni G; Sánchez MJ; Ligier K;
    Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S16-S23. PubMed ID: 28005601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of in situ and invasive breast cancer in women aged under 45.
    Weiss HA; Brinton LA; Brogan D; Coates RJ; Gammon MD; Malone KE; Schoenberg JB; Swanson CA
    Br J Cancer; 1996 May; 73(10):1298-305. PubMed ID: 8630296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
    Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correcting bias due to missing stage data in the non-parametric estimation of stage-specific net survival for colorectal cancer using multiple imputation.
    Falcaro M; Carpenter JR
    Cancer Epidemiol; 2017 Jun; 48():16-21. PubMed ID: 28315607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
    Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
    Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumours in Iceland. 10. Malignant tumours of the female breast. A histological classification, laterality, survival and epidemiological considerations.
    Tulinius H; Bjarnason O; Sigvaldason H; Bjarnadottir G; Olafsdottir G
    APMIS; 1988 Mar; 96(3):229-38. PubMed ID: 3348912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland.
    Schaffar R; Bouchardy C; Chappuis PO; Bodmer A; Benhamou S; Rapiti E
    PLoS One; 2019; 14(9):e0222136. PubMed ID: 31491032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis.
    van Maaren MC; Ávila AO; van Manen JG; Menke-Pluijmers MB; Veltman J; Bart J; Westenend PJ; Siesling S
    Breast; 2021 Oct; 59():376-382. PubMed ID: 34428722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.